These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10245673)

  • 1. FTC is cautious about health-plan rule on eve of Senate debate of agency power.
    Wall St J Midwest Ed; 1980 Feb; 60(80):14. PubMed ID: 10245673
    [No Abstract]   [Full Text] [Related]  

  • 2. FTC eyes hospital-BC relations.
    Simler SL
    Mod Healthc; 1979 Jun; 9(6):28. PubMed ID: 440277
    [No Abstract]   [Full Text] [Related]  

  • 3. FTC charges MDs control Blue Shield.
    Am Med News; 1979 May; 22(20):2. PubMed ID: 10242441
    [No Abstract]   [Full Text] [Related]  

  • 4. FTC moves more slowly against physician control in Blue Shield and other open-panel health plans.
    Employee Benefit Plan Rev; 1980 May; 34(11):49, 111. PubMed ID: 10278064
    [No Abstract]   [Full Text] [Related]  

  • 5. Physician agreements to control medical prepayment plans: Federal Trade Commission. Notice of initiation of case-by-case law enforcement program.
    Fed Regist; 1981 May; 46(98):27768-9. PubMed ID: 10251259
    [No Abstract]   [Full Text] [Related]  

  • 6. On "FTC Sings the Blues" and its respondents.
    Weller CD
    J Health Polit Policy Law; 1982; 7(2):547-58. PubMed ID: 7108176
    [No Abstract]   [Full Text] [Related]  

  • 7. Michigan law treats Blues plan like public agency, not private institution.
    LaViolette S
    Mod Healthc; 1981 Mar; 11(3):34, 36. PubMed ID: 10250327
    [No Abstract]   [Full Text] [Related]  

  • 8. FTC eyes ban of M.D. input into HMOs, Blues.
    Mod Healthc; 1979 Dec; 9(12):32. PubMed ID: 503022
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical participation in control of certain open-panel medical prepayment plans: Federal Trade Commission. Request for comment and advance notice of proposed rulemaking.
    Fed Regist; 1980 Mar; 45(53):17019-24. PubMed ID: 10245737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blue Shield ordered to repay withheld funds.
    Gosfield AG
    Pa Med; 1984 Jul; 87(7):34-5. PubMed ID: 6548007
    [No Abstract]   [Full Text] [Related]  

  • 11. As the trustbusters see it, everything doctors do is wrong.
    Paxton HT
    Med Econ; 1979 Mar; 56(5):37, 39, 42 passim. PubMed ID: 10240637
    [No Abstract]   [Full Text] [Related]  

  • 12. FTC sings the blues: a comment.
    Watts CA
    J Health Polit Policy Law; 1980; 5(3):568-72. PubMed ID: 7462585
    [No Abstract]   [Full Text] [Related]  

  • 13. Blue Cross and Blue Shield Plan contracts with providers: cost containment objectives amid conflicting legislative schemes.
    Heitler G; Ader M
    J Leg Med; 1981 Sep; 2(3):265-96. PubMed ID: 6976401
    [No Abstract]   [Full Text] [Related]  

  • 14. Washington believes it can control medical costs by reducing influence of doctors in Blue Shields.
    Schorr B
    Wall St J Midwest Ed; 1979 Mar; 59(103):40. PubMed ID: 10240386
    [No Abstract]   [Full Text] [Related]  

  • 15. Controversy over physicians on Blue Shield boards.
    Snyder JD; Bale C
    Physicians Manage; 1980 Feb; 20(2):115-6. PubMed ID: 10245724
    [No Abstract]   [Full Text] [Related]  

  • 16. Vertical restraints among hospitals, physicians and health insurers that raise rivals' costs. A case study of Reazin v. Blue Cross and Blue Shield of Kansas, Inc. and Ocean State Physicians Health Plan, Inc. v. Blue Cross and Blue Shield of Rhode Island.
    Baker JB
    Am J Law Med; 1988; 14(2-3):147-69. PubMed ID: 3245541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician influence on Blue Shield plans: a reexamination of the findings.
    Lynk W
    Socioecon Issues Health; 1979; ():129-42. PubMed ID: 10317229
    [No Abstract]   [Full Text] [Related]  

  • 18. Minimizing antitrust risks of Blue Cross and Blue Shield plans.
    Steele CJ
    J Contemp Health Law Policy; 1988; 4():227-72. PubMed ID: 10288422
    [No Abstract]   [Full Text] [Related]  

  • 19. Federal District Court refuses to apply "per se" rule in antitrust challenge to third party reimbursement policies.
    O'Brien JP
    Health Law Vigil; 1982 Aug; 5(17):6-8. PubMed ID: 10256277
    [No Abstract]   [Full Text] [Related]  

  • 20. Court holds that Blue Shield subscriber has antitrust standing.
    O'Brien JP
    Health Law Vigil; 1982 Jul; 5(15):5-7. PubMed ID: 10256013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.